Waters Corporation Schedules Fourth Quarter 2025 Earnings Conference Call

FierceBiotechNovo CEO insists ‘no change in plan’ for CagriSema launch after single-chamber device ditched

FierceBiotechAvalo’s phase 2 skin disease win fuels pursuit of AbbVie despite placebo headwind

Endpoints NewsNovo Nordisk's Q1 in four words: Pills, pricing, payments and pressure

LabiotechSickle cell disease after Casgevy: seven companies to watch in 2026

FierceBiotechJ&J’s Ottava surgical robot meets primary endpoints in gastric bypass study

Science Daily BiotechScientists boost strawberry flavor and nutrition without changing growth

FierceBiotechAfter Arcellx buyout close, Gilead trims 108 jobs at CAR-T biotech's Redwood City outpost

FDA News ReleasesFDA Expands Market Access, Authorizes New ENDS Products

Endpoints NewsIntercept's next-gen FXR agonist fails Phase 2 in latest setback for Italian-owned pharma

Clinical OMICsMuscle Quality and Fat Distribution Predict Mortality Risk Better than BMI

Endpoints NewsPfizer's Albert Bourla says he has no mega-merger plans

Clinical OMICsGenotype-Guided Antidepressants Could Have Long-Term Benefits